SHMT2 and colorectal carcinoma: Interestingly, we revealed that BRCC36 knockdown decreased β-catenin expression in CRC cells, suggesting that binding between SHMT2 and BRCC36 may direct BRCC36 activity towards K63-Ub chains conjugated to β-catenin in CRC cells.